dGenThera and Nusano Sign Letter of Intent for Astatine‑211 Supply
Alpha-emitting radioisotope expected to play an essential role in next-generation targeted cancer therapiesDURHAM, N.C. and WEST VALLEY CITY, Utah, June...
Pharmaceutical
CrazyBulk “Legal Steroid Alternatives” for Muscle Growth: A Safer Shift in Bodybuilding and Performance Nutrition 2025
crazybulk CrazyBulk New York City, NY, June 19, 2025 (GLOBE NEWSWIRE) -- As traditional anabolic steroids fall further out of...
Symbiotic.blue Launches to Combine Oxford and Cambridge Scientific Brain Power with Bioentrepreneurial Leadership to Reinvent AI Drug Discovery
LONDON, June 19, 2025 (GLOBE NEWSWIRE) -- Symbiotic.blue, the UK’s newest Techbio company has launched to innovate a next-generation artificial...
111, Inc. Announces First Quarter 2025 Unaudited Financial Results
Maintained Quarterly Operational ProfitabilityOperating Expenses as a Percentage of Revenues Decreased 30 Basis Points YoYMaintained Quarterly Positive Operating Cash FlowSHANGHAI,...
The Department of Health – Abu Dhabi and Sanofi Forge Strategic Alliance to Accelerate the Development of New Global Vaccines in Abu Dhabi
On the sidelines of a high-level US visit focused on healthcare innovation ABU DHABI, UAE, June 18, 2025 /PRNewswire/ --...
Cardiac Marker Testing Market Poised for Steady Growth, Driven by Point-of-Care Expansion
ARLINGTON, Va., June 18, 2025 /PRNewswire/ -- The global cardiac marker testing market is on track for sustained growth, according...
SandboxAQ Unveils SAIR, (Structurally Augmented IC50 Repository), a Novel Open Dataset of Protein-Ligand Structures Labelled By Binding Affinities
PALO ALTO, Calif., June 18, 2025 /PRNewswire/ -- SandboxAQ today announced the launch of SAIR (Structurally Augmented IC50 Repository), the...
Oklahoma Cancer Specialists and Research Institute Selects BioCareSD and AllyGPO as Primary Drug Distributor and GPO Partner
TULSA, Okla., June 18, 2025 /PRNewswire/ -- Oklahoma Cancer Specialists and Research Institute (OCSRI), a leading independent community oncology practice, has...
Petauri™ Further Expands Global Pricing and Market Access Capabilities With Key Leadership Hires
Rapidly growing pharmaceutical services platform announces the addition of accomplished executives to the organization's global pricing and market access team....
START Launches Hope Hub to Connect Patients, Physicians, and Advocacy Groups to Community-Based Cancer Trials
The new platform is designed to break down barriers to early-phase trial access, bringing "Hope Through Access" to communities and...
Blue Earth Diagnostics Reinforces Leadership in Prostate Cancer Imaging and Highlights Expanding Pipeline at Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2025
BOSTON, June 18, 2025 /PRNewswire/ -- Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of...
EY 2025 Biotech Beyond Borders Report: Biopharma — Focus on fundamentals to bounce back
Shifting policy environment creates regulatory and funding challenges: Policy changes will continue to cause uncertainty for the broader industry and...
Remepy’s Mobile App Shown to Rewire Brain, Modulate Immune System and Improve Mood in Adults with Subjective Cognitive Decline
RMPY-008 is the first app-based intervention to demonstrate rapid modulation of inflammatory blood biomarkers, acting like a digital antibody in...
Psyence BioMed Chief of Global Impact to Speak at Psychedelic Science 2025
Investors, Entrepreneurs, and Industry Experts to Convene at the Premier Psychedelic Science Business Forum hosted by Multidisciplinary Association for Psychedelic...
Tevogen Updates on Development of EBV-Specific T Cell Therapy with Support from AI-Powered Target Discovery
WARREN, N.J., June 18, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today provided an...
Lexicon to Present Data at the 85th Scientific Sessions of the American Diabetes Association (ADA)
Oral presentation on study demonstrating the ability of sotagliflozin to reduce the risk of hypoglycemic events regardless of kidney function...
Pacira BioSciences Debuts Inspiring New Film Highlighting One Patient’s Journey to Pain Relief and Innovation in Care at BIO 2025
- Produced for Pacira by BBC StoryWorks Commercial Productions, The Next Frontier: Mark & Leah’s Story Highlights the Impact of...
PharmaTher Applauds FDA’s New Commissioner’s National Priority Voucher (CNPV) Program, Citing Potential to Accelerate its Ketamine Programs for Mental Health, Pain, and Neurological Disorders, and National Security Applications
Provides Accelerated Path to Market for PharmaTher’s Ketamine-based Proprietary Delivery Systems & Orphan Drug Designations, and Leveraging its Ketamine Product,...
Aligos Therapeutics Appoints Kieron Wesson as Vice President, Head of Chemistry Manufacturing Controls (CMC)
SOUTH SAN FRANCISCO, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company...
Moleculin Participates in Virtual Investor “What This Means” Segment
Watch the “What This Means" segment here HOUSTON, June 18, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin”...